How much does Ruxolitinib cost?

Ruxolitinib works by blocking JAKs kinases, reducing the production of blood cells, thereby alleviating the symptoms of the disease. It is a drug used to treat adults with myelofibrosis who experience splenomegaly or other disease-related symptoms, such as fever, night sweats, bone pain and weight loss. Myelofibrosis is a disease in which the bone marrow becomes very dense and stiff and produces abnormal, immature blood cells.

Ruxolitinib tablets may also be used to treat polycythemia vera in adults in which the drug hydroxyurea (also called hydroxyurea) does not work or causes unacceptable side effects. In polycythemia vera, too many red blood cells are produced, which can lead to reduced blood flow to the organs due to "thickening" of the blood and the occasional formation of blood clots. For acute or chronic graft-versus-host disease (when transplanted cells attack the body), patients 12 years and older who have had a transplant and for whom corticosteroids or other systemic treatments (oral or injected treatments) are not effective enough, may also be treated with ruxolitinib tablets.

Ruxolitinib tabletsThe original drug has been launched in China and is included in the scope of Class B medical insurance. It is limited to patients who meet the indications. Specification The price of each box of 5mg*60 tablets may be around RMB 3,000. The Turkish version of ruxolitinib tablets listed overseas, Specifications20mg*56 tablets, may be priced around RMB 8,000 per box (the price may fluctuate due to exchange rates). There are also ruxolitinib tablets produced in other countries. For example, the price of 5mg*50 tablets produced by Bangladesh Yaopin International may be around 1,400 yuan per box (the price may fluctuate due to exchange rates). Its pharmaceutical ingredients are basically the same as those of domestic and foreign original drugs.